Our experts reveal how best to bridge the gap between ideal best practices and the practical realities of accurate data handling. Visit Cytel stand #21 and meet your peers in Vienna.
Be truly confident in your trial's enrollment plan. Use EnForeSys® and compare enrollment strategies, accurately predict milestones, and identify problem areas earlier.
Join Cytel and Sanofi in Cambridge, MA for our one day forum on early phase trial advances. Learn how to create adaptive trials with East® in the afternoon workshop.
--Simona Skerjanec, VP Medical Science
The Medicines Company
--Steven B. Ketchum, VP Research and Development
--Joe Heyes, VP
Early Stage Biostatistics Merck
--Dr. Scott Harris, CMO
--Dr. Patrice Rioux, VP, CMO
--Sylvain Nicolas, Global Head Biostatistics Phase 1 Studies